Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q2 2024 Earnings Call Transcript August 1, 2024
Regeneron Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $11.56, expectations were $10.62.
Operator: Welcome to the Regeneron Pharmaceuticals Second Quarter 2024 Earnings Conference Call. My name is Shannon and I will be your operator for today’s call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Please note that...
